APTO   $0.21  5.00% Market Closed After Close 0.2021 -3.76%

Aptose Biosciences Inc
Total Cash 8.33M
totalCashPerShare 0.46
EBITDA -40.85M
Total Debt 818.00K
quickRatio 0.655
currentRatio 0.799
Total Revenue
debtToEquity
Revenue/Share
ROA -1.36289
ROE -6.94126
grossProfits
freeCashflow -22.32M
operatingCashflow -37.34M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -583.35K
forwardPE -0.17296803
floatShares 13.31M
sharesOutstanding 18.11M
sharesShort 192.68K
sharesShortPriorMonth 818.68K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.17%
heldPercentInstitutions 0.16%
Short Ratio help_outline 2.19%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue -0.12
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -40.29M
trailingEps -4.24%
forwardEps -2.19%
enterpriseToEbitda 0.01
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.19 3Q 2024
institutionsCount 27
lastUpdated Nov. 6, 2024, 6:26 p.m.